Skip to main content
OpenTrials

Clinical trial condition

DNA Virus Infections

Explore clinical trials studying DNA Virus Infections. Study availability and eligibility vary by location and protocol.

3,920 public trials 503 recruiting studies
Refine in advanced search Browse all conditions

DNA Virus Infections trial results

Completed

Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination.

NCT00519649

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
Locations
  • GSK Investigational Site Birkenfeld, Baden-Wurttemberg, Germany
  • GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Heidelberg, Baden-Wurttemberg, Germany
  • GSK Investigational Site Karlsruhe, Baden-Wurttemberg, Germany
View all 35 locations
View Trial Details
Completed

Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects

NCT00578227

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • GSK Investigational Site Surrey, British Columbia, Canada
  • GSK Investigational Site Brampton, Ontario, Canada
  • GSK Investigational Site Greater Sudbury, Ontario, Canada
  • GSK Investigational Site Newmarket, Ontario, Canada
View all 21 locations
View Trial Details
Completed

Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects

NCT00652938

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • GSK Investigational Site Nijmegen, Netherlands
  • GSK Investigational Site Rotterdam, Netherlands
  • GSK Investigational Site Linköping, Sweden
  • GSK Investigational Site Luleå, Sweden
View Trial Details
Completed

Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children

NCT01506193

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations
  • GSK Investigational Site Rome, Lazio, Italy
  • GSK Investigational Site Chiavari, Liguria, Italy
  • GSK Investigational Site Genoa, Liguria, Italy
  • GSK Investigational Site Milan, Lombardy, Italy
View all 13 locations
View Trial Details
Completed

Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs

NCT00541970

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • GSK Investigational Site Edmonton, Alberta, Canada
  • GSK Investigational Site Langley, British Columbia, Canada
  • GSK Investigational Site St. John's, Newfoundland and Labrador, Canada
  • GSK Investigational Site Truro, Nova Scotia, Canada
View all 25 locations
View Trial Details

Related conditions